PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Netherlands Pharmacovigilance Centre Lareb, \'s-Hertogenbosch, the Netherlands.\', \'Netherlands Pharmacovigilance Centre Lareb, \'s-Hertogenbosch, the Netherlands. Electronic address: f.vanhunsel@lareb.nl.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(22)00028-710.1016/j.vaccine.2022.01.013
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 35067381
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35067381>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35067381>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all